K279-1439 Screening compound: 2-(5-{[(7-CHLORO-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDIN-2-YL)METHYL]SULFANYL}-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-3-YL)-N~1~-(2-METHOXYBENZYL)ACETAMIDE

K279-1439 Screening compound: 2-(5-{[(7-CHLORO-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDIN-2-YL)METHYL]SULFANYL}-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-3-YL)-N~1~-(2-METHOXYBENZYL)ACETAMIDE
K279-1439 Screening compound: 2-(5-{[(7-CHLORO-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDIN-2-YL)METHYL]SULFANYL}-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-3-YL)-N~1~-(2-METHOXYBENZYL)ACETAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound K279-1439
2-(5-{[(7-CHLORO-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDIN-2-YL)METHYL]SULFANYL}-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-3-YL)-N~1~-(2-METHOXYBENZYL)ACETAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K279-1439

Molecular Formula

C29H23ClN6O4S (C29 H23 ClN6 O4 S)

Compound Name

2-(5-{[(7-CHLORO-4-OXO-4H-PYRIDO[1,2-A]PYRIMIDIN-2-YL)METHYL]SULFANYL}-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-3-YL)-N~1~-(2-METHOXYBENZYL)ACETAMIDE

IUPAC name

n/a

SMILES

COc1c(CNC(CC2N3C(SCC(N=C(C=C4)N5C=C4Cl)=CC5=O)=Nc(cccc4)c4C3=NC2=O)=O)cccc1

InChI

InChI=1S/C29H23ClN6O4S/c1-40-23-9-5-2-6-17(23)14-31-25(37)13-22-28(39)34-27-20-7-3-4-8-21(20)33-29(36(22)27)41-16-19-12-26(38)35-15-18(30)10-11-24(35)32-19/h2-12,15,22H,13-14,16H2,1H3,(H,31,37)/t22-/m0/s1

InChI Key

BQGFONFJMYCBPT-QFIPXVFZSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

587.06

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

2.244

Distribution Coefficient, logD

2.243

Water Solubility, LogSw

-3.37

Polar Surface Area

93.759

Acid Dissociation Constant (pKa)

11.05

Base Dissociation Constant (pKb)

4.86

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

17.20

K279-1439 in Drug Discovery

Included in Screening Libraries

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with K279-1439 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K279-1439?
Check Price and Availability of K279-1439, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K279-1439 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K279-1439
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K279-1439
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K279-1439 available by request